Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma

Date
2013
Author
Ekenel, Meltem
Darendeliler, Emin
Disci, Rian
Duranyildiz, Derya
Bilgin, Elif
Bavbek, Sevil
Basaran, Mert
Yildiz, Ibrahim
Sen, Fatma
Keskin, Serkan
Kilic, Leyla
Metadata
Show full item record
Abstract
We aimed to investigate the prognostic significance of M30 and M65 which are biomarkers of apoptotic cell death in renal cell cancer (RCC). Serum levels of M30 and M65 were analyzed in 39 consecutively enrolled patients with metastatic RCC and control subjects using enzyme-linked immunosorbent assay (ELISA) kits. We found that high serum M65 levels might predict worse outcome resulting in shorter progression-free survival in RCC.
URI
http://hdl.handle.net/20.500.12627/21800
https://doi.org/10.1016/j.clgc.2013.01.001
Collections